{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:43:43Z","timestamp":1792813423732,"version":"4.5.0"},"reference-count":36,"publisher":"Japanese Circulation Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2026,10,23]]},"DOI":"10.1253\/circj.cj-26-0329","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:09:57Z","timestamp":1784239797000},"page":"1692-1703","source":"Crossref","is-referenced-by-count":0,"title":["Altered Plasma Urea Cycle Metabolites Are Independently Associated With Frailty in Patients With Heart Failure"],"prefix":"10.1253","volume":"90","author":[{"given":"Katsuhiko","family":"Ohori","sequence":"first","affiliation":[{"name":"Division of Cardiovascular-Kidney-Metabolic Medicine, Department of Internal Medicine, Sapporo Medical University School of Medicine"},{"name":"Department of Cardiology, Hokkaido Cardiovascular Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Yano","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular-Kidney-Metabolic Medicine, Department of Internal Medicine, Sapporo Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Katano","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Sapporo Medical University School of Medicine"},{"name":"Division of Rehabilitation, Sapporo Medical University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidemichi","family":"Kouzu","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular-Kidney-Metabolic Medicine, Department of Internal Medicine, Sapporo Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Nagaoka","sequence":"additional","affiliation":[{"name":"Division of Rehabilitation, Sapporo Medical University Hospital"},{"name":"Graduate School of Medicine, Sapporo Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Numazawa","sequence":"additional","affiliation":[{"name":"Division of Rehabilitation, Sapporo Medical University Hospital"},{"name":"Graduate School of Medicine, Sapporo Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Yamano","sequence":"additional","affiliation":[{"name":"Division of Rehabilitation, Sapporo Medical University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguru","family":"Honma","sequence":"additional","affiliation":[{"name":"Graduate School of Medicine, Sapporo Medical University"},{"name":"Department of Rehabilitation, Sapporo Cardiovascular Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki","family":"Habaguchi","sequence":"additional","affiliation":[{"name":"Division of Rehabilitation, Sapporo Medical University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takefumi","family":"Fujito","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular-Kidney-Metabolic Medicine, Department of Internal Medicine, Sapporo Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Nagano","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular-Kidney-Metabolic Medicine, Department of Internal Medicine, Sapporo Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Umemoto","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Sapporo Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Furuhashi","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular-Kidney-Metabolic Medicine, Department of Internal Medicine, Sapporo Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Lai HY, Huang ST, Anker SD, von Haehling S, Akishita M, Arai H, et al. The burden of frailty in heart failure: Prevalence, impacts on clinical outcomes and the role of heart failure medications. <i>J Cachexia Sarcopenia Muscle<\/i> 2024; 15: 660\u2013670.","DOI":"10.1002\/jcsm.13412"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Correale M, Salzano A, Tricarico L, Cittadini A, Crisci G, Dattilo G, et al. Non cardiovascular comorbidities in heart failure. An updated position paper from the Heart Failure Working Group of the Italian Society of Cardiology (SIC). <i>Eur J Intern Med<\/i> 2025; 140: 106457.","DOI":"10.1016\/j.ejim.2025.106457"},{"key":"3","unstructured":"3. Denfeld QE, Winters-Stone K, Mudd JO, Gelow JM, Kurdi S, Lee CS. Frailty in heart failure: Prevalence, associations, and clinical implications. <i>Eur J Heart Fail<\/i> 2017; 19: 1495\u20131506."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Sekiya Y, Fujiki S, Tsuchiya H, Kashimura T, Okura Y, Kodera K, et al. Association of medication profiles, including polypharmacy, guideline-directed medical therapy, and potentially inappropriate medications, with all-cause mortality in older adults with heart failure, with or without frailty and disability. <i>Circ J<\/i> 2025; 89: 1662\u20131671.","DOI":"10.1253\/circj.CJ-25-0200"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tsurumoto K, Kamisaka K, Nakane E, Inoko M, Uemura K. Association of frailty assessed by the Kihon Checklist upon the readmission of older patients with heart failure. <i>Circ J<\/i> 2025; 89: 457\u2013462.","DOI":"10.1253\/circj.CJ-24-0908"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ohori K, Yano T, Katano S, Nagaoka R, Numazawa R, Yamano K, et al. Coexistence of sarcopenia and self-reported weight loss is a powerful predictor of mortality in older patients with heart failure. <i>Geriatr Gerontol Int<\/i> 2024; 24: 95\u2013101.","DOI":"10.1111\/ggi.14778"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kitai T, Kohsaka S, Kato T, Kato E, Sato K, Teramoto K, et al. JCS\/JHFS 2025 Guideline on diagnosis and treatment of heart failure. <i>Circ J<\/i> 2025; 89: 1278\u20131444.","DOI":"10.1253\/circj.CJ-25-0002"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kouzu H, Katano S, Yano T, Ohori K, Nagaoka R, Inoue T, et al. Plasma amino acid profiling improves predictive accuracy of adverse events in patients with heart failure. <i>ESC Heart Fail<\/i> 2021; 8: 5045\u20135056.","DOI":"10.1002\/ehf2.13572"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Gonz\u00e1lez-Beltr\u00e1n D, Y\u00e9venes-Briones H, Lana A, C\u00e1rdenas-Valladolid J, Salinero-Fort MA, Rodr\u00edguez-Artalejo F, et al. Prospective association between plasma amino acids and healthy aging in older adults. <i>J Intern Med<\/i> 2025; 298: 123\u2013134, doi:10.1111\/joim.20105.","DOI":"10.1111\/joim.20105"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yuan Y, Huang X, Lin S, Lin W, Huang F, Zhu P. Metabolomics-based identification and validation of the creatine precursor guanidinoacetic acid for frailty in older adults. <i>J Gerontol A Biol Sci Med Sci<\/i> 2025; 80: glaf127.","DOI":"10.1093\/gerona\/glaf127"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hiraiwa H, Okumura T, Murohara T. Amino acid profiling to predict prognosis in patients with heart failure: An expert review. <i>ESC Heart Fail<\/i> 2023; 10: 32\u201343.","DOI":"10.1002\/ehf2.14222"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Zhang S, Wang Z, Wang Y, Zhu Y, Zhou Q, Jian X, et al. A metabolomic profile of biological aging in 250,341 individuals from the UK Biobank. <i>Nat Commun<\/i> 2024; 15: 8081.","DOI":"10.1038\/s41467-024-52310-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Panyard DJ, Yu B, Snyder MP. The metabolomics of human aging: Advances, challenges, and opportunities. <i>Sci Adv<\/i> 2022; 8: eadd6155.","DOI":"10.1126\/sciadv.add6155"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Satake S, Arai H. The revised Japanese version of the Cardiovascular Health Study criteria (revised J-CHS criteria). <i>Geriatr Gerontol Int<\/i> 2020; 20: 992\u2013993.","DOI":"10.1111\/ggi.14005"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ishigo T, Katano S, Yano T, Kouzu H, Ohori K, Nakata H, et al. Overestimation of glomerular filtration rate by creatinine-based equation in heart failure patients is predicted by a novel scoring system. <i>Geriatr Gerontol Int<\/i> 2020; 20: 752\u2013758.","DOI":"10.1111\/ggi.13959"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Kouzu H, Yano T, Katano S, Kawaharata W, Ogura K, Numazawa R, et al. Adverse plasma branched-chain amino acid profile mirrors fatty muscle degeneration in diabetic heart failure patients. <i>ESC Heart Fail<\/i> 2024; 11: 2941\u20132953, doi:10.1002\/ehf2.14872.","DOI":"10.1002\/ehf2.14872"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Katano S, Yamano K, Yano T, Numazawa R, Nagaoka R, Honma S, et al. Prognostic implication of sarcopenia diagnosed by updated Asian Working Group for Sarcopenia criteria in older patients with heart failure: Utility and limitation. <i>J Nutr Health Aging<\/i> 2025; 29: 100434.","DOI":"10.1016\/j.jnha.2024.100434"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. F\u00f6rstermann U, Sessa WC. Nitric oxide synthases: Regulation and function. <i>Eur Heart J<\/i> 2012; 33: 829\u2013837.","DOI":"10.1093\/eurheartj\/ehr304"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Morris SM Jr. Arginine metabolism: Boundaries of our knowledge. <i>J Nutr<\/i> 2007; 137(Suppl 2): 1602S\u20131609S.","DOI":"10.1093\/jn\/137.6.1602S"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Wu G, Morris SM Jr. Arginine metabolism: Nitric oxide and beyond. <i>Biochem J<\/i> 1998; 336: 1\u201317.","DOI":"10.1042\/bj3360001"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. <i>J Clin Invest<\/i> 2003; 111: 1201\u20131209.","DOI":"10.1172\/JCI200314172"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kim ME, Lee JS. Advances in the regulation of inflammatory mediators in nitric oxide synthase: Implications for disease modulation and therapeutic approaches. <i>Int J Mol Sci<\/i> 2025; 26: 1204.","DOI":"10.3390\/ijms26031204"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Heusch P, Aker S, Boengler K, Deindl E, van de Sand A, Klein K, et al. Increased inducible nitric oxide synthase and arginase II expression in heart failure: No net nitrite\/nitrate production and protein S-nitrosylation. <i>Am J Physiol Heart Circ Physiol<\/i> 2010; 299: H446\u2013H453.","DOI":"10.1152\/ajpheart.01034.2009"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Pernow J, Jung C. Arginase as a potential target in the treatment of cardiovascular disease: Reversal of arginine steal? <i>Cardiovasc Res<\/i> 2013; 98: 334\u2013343.","DOI":"10.1093\/cvr\/cvt036"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Windmueller HG, Spaeth AE. Source and fate of circulating citrulline. <i>Am J Physiol<\/i> 1981; 241: E473\u2013E480.","DOI":"10.1152\/ajpendo.1981.241.6.E473"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, et al. Wasting as independent risk factor for mortality in chronic heart failure. <i>Lancet<\/i> 1997; 349: 1050\u20131053.","DOI":"10.1016\/S0140-6736(96)07015-8"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Sandek A, Swidsinski A, Schroedl W, Watson A, Valentova M, Herrmann R, et al. Intestinal blood flow in patients with chronic heart failure: A link with bacterial growth, gastrointestinal symptoms, and cachexia. <i>J Am Coll Cardiol<\/i> 2014; 64: 1092\u20131102.","DOI":"10.1016\/j.jacc.2014.06.1179"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Lundberg JO, Gladwin MT, Weitzberg E. Strategies to increase nitric oxide signalling in cardiovascular disease. <i>Nat Rev Drug Discov<\/i> 2015; 14: 623\u2013641.","DOI":"10.1038\/nrd4623"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello C, Sciorati C, et al. Mitochondrial biogenesis in mammals: The role of endogenous nitric oxide. <i>Science<\/i> 2003; 299: 896\u2013899.","DOI":"10.1126\/science.1079368"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Tang WHW, Shrestha K, Wang Z, Troughton RW, Klein AL, Hazen SL. Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failure. <i>J Card Fail<\/i> 2013; 19: 87\u201393.","DOI":"10.1016\/j.cardfail.2013.01.001"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Schwedhelm E, Maas R, Freese R, Jung D, Lukacs Z, Jambrecina A, et al. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: Impact on nitric oxide metabolism. <i>Br J Clin Pharmacol<\/i> 2008; 65: 51\u201359.","DOI":"10.1111\/j.1365-2125.2007.02990.x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Balderas-Munoz K, Castillo-Mart\u00ednez L, Orea-Tejeda A, Infante-V\u00e1zquez O, Utrera-Lagunas M, Mart\u00ednez-Memije R, et al. Improvement of ventricular function in systolic heart failure patients with oral l-citrulline supplementation. <i>Cardiol J<\/i> 2012; 19: 612\u2013617.","DOI":"10.5603\/CJ.2012.0113"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Yun HR, Singh MK, Han S, Ranbhise JS, Ha J, Kim SS, et al. Biomarkers of cardiac metabolic flexibility in health, HFrEF and HFpEF. <i>Int J Mol Sci<\/i> 2026; 27: 879.","DOI":"10.3390\/ijms27020879"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Xia J, Nong Y, Teng J, Mohammed SA, Liu J, Pang Y, et al. Unlocking metabolic flexibility in heart failure with preserved ejection fraction: Bridging fundamental mechanisms to clinical innovation. <i>iScience<\/i> 2025; 28: 113471.","DOI":"10.1016\/j.isci.2025.113471"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Hage C, L\u00f6fgren L, Michopoulos F, Nilsson R, Davidsson P, Kumar C, et al. Metabolomic profile in HFpEF vs HFrEF patients. <i>J Card Fail<\/i> 2020; 26: 1050\u20131059.","DOI":"10.1016\/j.cardfail.2020.07.010"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Bletsa E, Filippas-Dekouan S, Kostara C, Dafopoulos P, Dimou A, Pappa E, et al. Effect of dapagliflozin on urine metabolome in patients with Type 2 diabetes. <i>J Clin Endocrinol Metab<\/i> 2021; 106: 1269\u20131283.","DOI":"10.1210\/clinem\/dgab086"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/11\/90_CJ-26-0329\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:23:38Z","timestamp":1792812218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/11\/90_CJ-26-0329\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-26-0329","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"article-number":"CJ-26-0329"}}